Coverage, context and targeted prevention: Optimising our impact

Sexually Transmitted Infections

Volumn 89, Issue 4, 2013, Pages 336-340

  Aral, Sevgi O ^a   Cates Jr , Willard ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 LYMPHOCYTE COUNT; CIRCUMCISION; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH INSURANCE; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; MEN WHO HAVE SEX WITH MEN; PREVENTION STUDY; PRIORITY JOURNAL; PROSTITUTION; RESOURCE ALLOCATION; REVIEW; SCALE UP; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; STRATEGIC PLANNING; VULNERABLE POPULATION;

HIV; PROGRAMME SCIENCE; SEXUAL BEHAVIOUR;

ADENINE; ANTI-HIV AGENTS; CIRCUMCISION, MALE; DEOXYCYTIDINE; FEMALE; HEALTH PRIORITIES; HIV INFECTIONS; HUMANS; MALE; ORGANOPHOSPHONATES; SEXUAL BEHAVIOR; UNITED STATES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84878197717     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050707     Document Type: Review

References (30)

1. Siegfried N, Muller M, Deeks JJ, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009;(2): CD003362. http://www.ncbi.nlm.nih.gov/pubmed/19370585 (accessed 30 Apr 2012).
2. Karim Abdool Q, Karim Abdool SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. Lancet 2009;373:48-57.
4. Thigpen MC, Kebaabetswe PM, Smith DK, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 Study. In: Abstracts of the 6th International AIDS Society Conference; 2011 July 17-20; Abstract WELBC01. Rome, Italy: International AIDS Society, 2011.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
6. Aral SO, Blanchard J, Lipshutz J. STD/HIV prevention intervention: efficacy, effectiveness and population impact. Sex Transm Infect 2008;84(Suppl II):ii1-13.
7. Global HIV Prevention Working Group. Bringing HIV prevention to scale: an urgent global priority. http://www.globalhivprevention.org (accessed 21 Aug 2008).
8. Manhart LE, Holmes KK. Randomized controlled trials of individual level, population level, and multilevel interventions for preventing sexually transmitted infections: what has worked?. J Infect Dis 2005;191(Suppl I):S7-24.
9. Mavedzenge SN, Weiss HA, Montgomery ET, et al. Determinants of differential HIV incidence among women in three southern African locations. J Acquir Immune Defic Syndr 2011;58:89-99.
10. Grassly NC, Garnett GP, Schwartländer B, et al. The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ 2001;79:1121-32. http://dx.doi.org/10.1590/S0042-96862001001200008 (accessed 10 Apr 2012). (Pubitemid 34084005)
11. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011;56:e45-8.
12. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996;174(Suppl 2):S201-13. (Pubitemid 26326158)
13. Vickerman P, Hickman M, Rhodes T, et al. Model projections on the required coverage of sypringe distribution to prevent HIV epidemics among injecting drug users. J Acquir Immune Defic Syndr 2006;42:355-61. (Pubitemid 44050015)
14. Aral SO, Lipshutz JA, Douglas JM. Introduction. In: Aral SO, Douglas JM Jr, Lipshutz JA, eds. Assoc. ed. Behavioral interventions for prevention and control of sexually transmitted diseases. New York: Springer Science+Business Media, LLC, 2007:ix-xviii.
15. Mangham L, Hanson K. Scaling up in international health: what are the key issues? Health Policy Plan 2010;25:85-96.
16. Hanson K, Ranson MK, Oliveira-Cruz V, et al. Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. J Int Dev 2003;15:1-14. (Pubitemid 36175340)
17. Gray RH, Wawer MJ, Kigozi G. Program science research on medical male circumcision scale up in sub-Saharan Africa. Sex Transm Infect 2012 (In press).
18. Victora CG, Wagstaff A, Armstrong Schellenberg J, et al. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet 2003;362:233-41. (Pubitemid 36859944)
19. Victora CG, Hanson K, Bryce J, et al. Achieving universal coverage with health interventions. Lancet 2004;364:1541-8. (Pubitemid 39410422)
20. Victora C. MDGS and equity: progress and challenges. Countdown to 2015: Maternal, Newborn & Child Survival 2011. http://www.wilsoncenter.org/sites/ default/files/Victora%20Presentation.pdf (accessed 2 May 2012).
21. Alistar SS, Brandeau ML. Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Med Decis Making 2012;32:105-17.
22. Aral SO, Wasserheit JN. STD-related health care seeking and health service delivery. In: Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, Wasserheit JN, eds. Sexually transmitted diseases. 3rd edn. New York, USA: McGraw Hill, 1999:1295-305.
23. Aral SO, Hogben M, Wasserheit JN. STD-related health-care SEEKING and health service delivery. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, eds. Sexually transmitted diseases. 4th edn. New York, USA: McGraw Hill, 2008:1803-20.
24. Pilcher CD, Tien HC, Eron JJ, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004;189:1785-92. (Pubitemid 38657214)
25. Eaton JW, Hallett TB, Garnett GP. Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav 2011;15:687-92.
26. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modeling study. Lancet 2011;378:256-68.
27. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized control trial. Lancet 1995;346:530-6.
28. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Rakai Project Study Group. Lancet 1999;353:525-35. (Pubitemid 29078422)
29. Grosskurth H, Gray R, Hayes R, et al. Control of sexually transmitted disease for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000;355:1981-7. (Pubitemid 30326108)
30. Auvert B, Sitta R, Zarca K, et al. The effect of heterogeneity on HIV prevention trials. Clin Trials 2011;8:144-54.